Wellington Management Group LLP Trims Position in Encompass Health Corporation $EHC

Wellington Management Group LLP decreased its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 14.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,278,739 shares of the company's stock after selling 570,116 shares during the quarter. Wellington Management Group LLP owned approximately 3.32% of Encompass Health worth $331,415,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of EHC. Royal Bank of Canada raised its stake in Encompass Health by 21.5% during the first quarter. Royal Bank of Canada now owns 88,470 shares of the company's stock worth $8,960,000 after purchasing an additional 15,677 shares during the period. Millennium Management LLC grew its stake in shares of Encompass Health by 38.4% in the 1st quarter. Millennium Management LLC now owns 92,197 shares of the company's stock valued at $9,338,000 after buying an additional 25,574 shares during the period. Caxton Associates LLP acquired a new stake in shares of Encompass Health during the 1st quarter worth approximately $259,000. Walleye Capital LLC increased its holdings in shares of Encompass Health by 667.6% during the 2nd quarter. Walleye Capital LLC now owns 6,522 shares of the company's stock worth $800,000 after buying an additional 7,671 shares during the last quarter. Finally, Gamco Investors INC. ET AL purchased a new stake in shares of Encompass Health during the 2nd quarter valued at approximately $588,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Mark J. Tarr sold 173,148 shares of the firm's stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the transaction, the chief executive officer directly owned 267,814 shares in the company, valued at $33,602,622.58. This trade represents a 39.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP John Patrick Darby sold 8,906 shares of Encompass Health stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the transaction, the executive vice president directly owned 75,041 shares of the company's stock, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.80% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Barclays increased their price objective on Encompass Health from $140.00 to $144.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Wall Street Zen raised Encompass Health from a "hold" rating to a "buy" rating in a research note on Sunday, August 16th. Leerink Partners set a $152.00 price target on Encompass Health in a report on Friday, May 22nd. Weiss Ratings raised Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, August 12th. Finally, TD Cowen boosted their price objective on shares of Encompass Health from $125.00 to $140.00 and gave the company a "buy" rating in a report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $148.71.

Encompass Health Stock Performance

NYSE:EHC opened at $120.98 on Monday. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.19 and a current ratio of 1.19. The company has a 50 day moving average price of $113.20 and a 200 day moving average price of $107.19. The stock has a market capitalization of $11.93 billion, a P/E ratio of 19.70, a PEG ratio of 2.45 and a beta of 0.72.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same quarter in the previous year, the company earned $1.40 earnings per share. The firm's quarterly revenue was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Equities research analysts forecast that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0.21 dividend. The ex-dividend date is Thursday, October 1st. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. This is a boost from Encompass Health's previous quarterly dividend of $0.19. Encompass Health's dividend payout ratio (DPR) is presently 12.38%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source